BigHat

San Carlos, United States Founded: 2019 • Age: 7 yrs
Antibody therapies are developed through machine learning and synthetic biology.
Request Access

About BigHat

BigHat is a company based in San Carlos (United States) founded in 2019 by Peyton Greenside and Mark DePristo.. BigHat has raised $148.41 million across 3 funding rounds from investors including Bristol-Myers Squibb, Amgen Business Development and Quadrille Capital. BigHat has completed 1 acquisition, including BigHat Biosciences. BigHat offers products and services including Milliner Platform. BigHat operates in a competitive market with competitors including argenx, MacroGenics, Owkin, Formation Bio and Alexion, among others.

  • Headquarter San Carlos, United States
  • Founders Peyton Greenside, Mark DePristo
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $148.41 M (USD)

    in 3 rounds

  • Latest Funding Round
    $124.11 M (USD), Series B

    Jun 30, 2022

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BigHat

BigHat offers a comprehensive portfolio of products and services, including Milliner Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Integrates machine learning and wet lab for faster antibody engineering and design

People of BigHat
Headcount 10-50
Employee Profiles 33
Board Members and Advisors 17
Employee Profiles
People
Austin Prater
Senior Scientist
People
Jennifer Yao
Senior Scientist, Protein Purification
People
Eva Boettcher
Senior Research Associate
People
Emily Delaney
Senior Platform Scientist

Unlock access to complete

Board Members and Advisors
people
Steve Doberstein
Advisor
people
Jacob Gardner
Advisor
people
Pauline Jen Ryan
Advisor
people
Andrew Gordon Wilson
Advisor

Unlock access to complete

Funding Insights of BigHat

BigHat has successfully raised a total of $148.41M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $124.11 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series B — $124.1M
  • First Round

    (19 Dec 2019)

  • Investors Count 10
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2022 Amount Series B - BigHat Valuation S32
Feb, 2021 Amount Series A - BigHat Valuation a16z
Dec, 2019 Amount Series A - BigHat Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BigHat

BigHat has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Bristol-Myers Squibb, Amgen Business Development and Quadrille Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital investments are facilitated by Amgen-backed entity.
Founded Year Domain Location
Sector-agnostic investment company making venture capital investments globally
Founded Year Domain Location
Venture capital investing with a focus on diversity and inclusion in the ecosystem.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BigHat

BigHat has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BigHat Biosciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Synthetic biology platform provided for diagnostic and therapeutic applications.
1976
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - BigHat

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bighat Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BigHat

BigHat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as argenx, MacroGenics, Owkin, Formation Bio and Alexion, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
domain founded_year HQ Location
A biopharmaceutical company focused on cancer therapeutics development.
domain founded_year HQ Location
An agentic AI platform is developed for biomedical research insights.
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
Therapies for rare and devastating diseases are developed by Alexion.
domain founded_year HQ Location
Antibody-based therapies for cancers and inflammatory diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bighat

Frequently Asked Questions about BigHat

When was BigHat founded?

BigHat was founded in 2019.

Where is BigHat located?

BigHat is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.

Who is the current CEO of BigHat?

Mark DePristo is the current CEO of BigHat. They have also founded this company.

Is BigHat a funded company?

BigHat is a funded company, having raised a total of $148.41M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5.3M, raised on Dec 19, 2019.

What does BigHat do?

BigHat was founded in 2019 and is based in San Carlos, United States. Antibody therapies are provided by the company using machine learning and synthetic biology. An AI-enabled platform called Milliner is offered to design antibodies targeting intractable conditions, including chronic illnesses and life-threatening diseases. Operations focus on the biotechnology sector, with services aimed at therapeutic development for complex health challenges.

Who are the top competitors of BigHat?

BigHat's top competitors include argenx, Owkin and Formation Bio.

What products or services does BigHat offer?

BigHat offers Milliner Platform.

How many acquisitions has BigHat made?

BigHat has made 1 acquisition, including BigHat Biosciences.

Who are BigHat's investors?

BigHat has 10 investors. Key investors include Bristol-Myers Squibb, Amgen Business Development, Quadrille Capital, Gaingels, and GRIDS Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available